Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Conditions:   Esophageal Adenocarcinoma;   Gastric Adenocarcinoma;   Stage IIB Gastric Cancer;   Stage IIIA Esophageal Adenocarcinoma;   Stage IIIA Gastric Cancer;   Stage IIIB Esophageal Adenocarcinoma;   Stage IIIB Gastric Cancer;   Stage IIIC Esophageal Adenocarcinoma;   Stage IIIC Gastric Cancer
Interventions:   Drug: Oxaliplatin;   Drug: Leucovorin Calcium;   Drug: Irinotecan Hydrochloride;   Drug: Fluorouracil;   Procedure: Conventional Surgery
Sponsors:   University of Chicago;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 6, 2020 / by / in
Comments